Try our Advanced Search for more refined results
Tung v. Bristol-Myers Squibb Company et al
Case Number:
1:18-cv-01611
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Bernstein Litowitz
- Bleichmar Fonti
- Grant & Eisenhofer
- Kirkland & Ellis
- Labaton Keller
- Motley Rice
- Pomerantz LLP
Companies
Sectors & Industries:
-
March 11, 2022
2nd Circ. Backs Dismissal of Bristol-Myers Clinical Trial Suit
The Second Circuit on Friday agreed with a New York federal court that investors hadn't shown that Bristol-Myers hid information about patients in a clinical trial for a new lung cancer drug, holding that the shareholders failed to allege a material misstatement or omission made by the company.
-
October 01, 2020
Bristol-Myers Squibb Escapes Investor Suit Over Clinical Trial
For the second and final time, a New York federal judge on Wednesday dismissed an investor suit against Bristol-Myers Squibb that alleged the pharmaceutical company hid information about patients in a clinical trial for a new lung cancer drug, saying the investors again didn't show the company or its executives misled them.
-
September 11, 2018
Bristol-Myers Looks To Ax Investor Suit Over Clinical Trial
Bristol-Myers Squibb asked a New York federal judge on Tuesday to toss a proposed class action alleging it misled investors about the clinical trial patients for its new lung cancer drug, saying the investors have yet to show a material misstatement or omission made by the company.